Rankings
Publications
Sources
Publishers
Scholars
Organizations
About
Login
Register
Home
Publications
Supplementary Table S3 from Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin
Home
Publications
Supplementary Table S3 from Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin
Supplementary Table S3 from Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin
CC
Carissa E. Chu
Carissa E. Chu
Martin Sjöström
Martin Sjöström
EE
Emily A. Egusa
Emily A. Egusa
EG
Ewan A. Gibb
Ewan A. Gibb
MB
Michelle L. Badura
Michelle L. Badura
JZ
Jun Zhu
Jun Zhu
VK
Vadim S. Koshkin
Vadim S. Koshkin
BS
Bradley A. Stohr
Bradley A. Stohr
MM
Maxwell V. Meng
Maxwell V. Meng
RP
Raj S. Pruthi
Raj S. Pruthi
Terence W. Friedlander
Terence W. Friedlander
Yair Lotan
Yair Lotan
See more
Open Access
Publisher Website
Google Scholar
Cite
Download
Share
Download
31 March 2023
other
Published by
American Association for Cancer Research (AACR)
https://doi.org/10.1158/1078-0432.22481559.v1
Abstract
The p values from pairwise comparisons amongst the molecular subtypes for each cohort using the Wilcoxon rank-sum test are shown.
Keywords
TABLE
UROTHELIAL
RANK
ENFORTUMAB
NECTIN4
SUM
WILCOXON
VEDOTIN
PAIRWISE
All Articles
Open Access